euNetworks delivers new critical infrastructure in Europe - a shorter long haul fibre route from Amsterdam to Frankfurt
euNetworks Group Limited (“euNetworks”), a European critical bandwidth infrastructure company, today announced that it has delivered its next Super Highway to market - a shorter long haul fibre route from Amsterdam to Frankfurt. Super Highways are new and uniquely routed state-of-the-art fibre networks. These long haul routes are critical to Europe’s future bandwidth needs and are built, owned and operated by euNetworks. This is the third of the company’s Super Highways now live - its Dublin to London route, including subsea cable Rockabill went live in 2019 and its London to Amsterdam route, including subsea cable Scylla went live in 2021. euNetworks is constructing and developing the next-generation of critical bandwidth infrastructure in Europe that is vital to supporting the bandwidth demands from customers today and the demands that technology such as Generative AI and Machine Learning will drive in the future.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241003306875/en/
Kevin Dean, Interim CEO of euNetworks (Photo: Business Wire)
This latest Super Highway was designed in response to the increased demand euNetworks sees on the important connectivity route between Amsterdam and Frankfurt. The company took its existing path as a starting place, then redesigned it to be a Super Highway.
The new Super Highway has delivered:
1. A shorter Amsterdam to Frankfurt fibre route.
2. Infrastructure redesigned to modern fibre specifications to improve the power efficiency and performance of the network, yielding a lower associated carbon impact of the new system and a lower cost per bit of operating it.
- This was achieved by developing new and more secure repeater (ILA) sites, redesigned with optimal and longer spacing between each site, and a subsequent reduction from 7 to 5 ILA sites across the system.
- New modern fibre (low loss G657A1), coupled with the reduction in ILAs, was used for best available photonic performance whilst maintaining full compatibility with existing fibre networks.
3. Enhanced diversity as the Super Highway route was designed to avoid existing routes and bottlenecks.
- The optimised long haul approach to the Amsterdam metro network in the South East avoids route congestion bound for Hamburg.
- Diversity has been enhanced in the euNetworks Frankfurt metro network, with a direct route into Sossenheim and direct approach to Hattersheim, thus providing space for a direct Brussels to Frankfurt route without crossovers.
4. The flexibility to connect directly to any of the 136+ data centres euNetworks directly connects in its metro networks in Amsterdam, Dusseldorf, Cologne and Frankfurt along this Super Highway system, as well as seamlessly connecting to the other 409+ of euNetworks’ portfolio of 545+ connected data centres on their fibre-based networks and Super Highways across Europe.
Kevin Dean, Interim Chief Executive of euNetworks, said, “Super Highways are part of euNetworks' investment in the future of Europe's bandwidth infrastructure, and specifically, fibre connectivity between data centres, hubs and data clusters. They’re a strategic priority for us as we continue to focus on supporting our customers with fibre-based data to data centre connectivity. We’ve designed these networks with our customers to ensure they’re directly serving customer’s ever-growing bandwidth needs across Europe, and we’re concentrating on delivering in areas of high bandwidth demand and congestion first. Today that spans connections between Frankfurt, London, Amsterdam, Paris and Dublin (FLAP-D).”
“With our Amsterdam to Frankfurt Super Highway, we've delivered new, state-of-the-art fibre infrastructure in one of the busiest bandwidth regions in Europe,” added Dean. “This brings substantial new fibre capacity on a highly efficient new system, and new route diversity that avoids existing high-traffic areas. I’m delighted to say that this is the first of a number of innovative construction projects going live in the coming months, which makes it an exciting time for the business and for the industry. Thank you to the euNetworks team and to our suppliers and partners who’ve been working so hard together to deliver what we do best – unique, innovative and truly scalable fibre networks.”
euNetworks builds and invests in city and long haul fibre networks to connect key European data centres and data hubs. The company owns and operates deep fibre networks in 18 cities as well as a highly differentiated long haul network that spans 45,200 route kilometres across 17 countries. As a specialist in the sector, euNetworks continues to grow and invest in partnership with its customers, supporting new technologies and deepening its unique fibre networks in Europe. These investments fuel the company’s growth.
About euNetworks
euNetworks is a critical bandwidth infrastructure company, owning and operating 18 fibre-based metropolitan networks connected with a high capacity intercity backbone covering 53 cities in 17 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 545 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs.
The company delivers services with an active commitment to sustainability and is focused on its path to being carbon emissions net zero, environmentally responsible supply chain management and working as a community and industry to collaborate on the environmental challenges ahead. For further information visit eunetworks.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241003306875/en/
Contacts
Hannah Britt| Chief Marketing Officer |euNetworks
hannah.britt@eunetworks.com email
| +44 7717 896 446 mobile
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 22:46:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 22:35:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 21:32:00 EET | Press release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 14:00:00 EET | Press release
TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 14:00:00 EET | Press release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom